Biomedical Research Center of the Slovak Academy of Sciences

The challenges of human health and diseases are very complex and the Biomedical Research Center of the Slovak Academy of Sciences is able to look at them from different perspectives, as it comprises five areas of biomedical research: experimental endocrinology, experimental oncology, virology, neurobiology as well as clinical and translational research. The Biomedical Research Center is a multidisciplinary institution of basic and translational research. We focus on the study of human disease mechanisms and their interactions and on the development of new preventive, screening and diagnostic approaches that are not yet available in current medical practice in Slovakia. We aim to contribute to the explanation of the causes, mechanisms and consequences of metabolic, neurobiological, neuroendocrine, autoimmune, cardiovascular, oncological and infectious diseases and to develop new strategies for combating these diseases, that represent a great health, social and economic burden on our society.

Read More

Babraham Institute – Ageing research for lifelong health

The Babraham Institute is a centre for discovery research in human biology with a view to understanding how our bodies work and what changes with age and disease. As a pioneering fundamental life science institute, our overarching aims are to understand the human biology that underpins health. Our research provides the bedrock for interventions that promote health and tackle age-related decline, thereby maximising heath span – the numbers of years lived in good health.

Our 20 research groups, grouped by area of focus into three research programmes: epigenetics, signalling and immunology, possess expertise in defining the molecular and cellular details that determine cell identity, human development, the effect of diet on health through epigenetic mechanisms, how our immune systems develop and respond to threats, the effect of age on the function of the immune system, protein quality control, the biology of protein aggregation, cellular recycling and cellular fitness.

Read More

Cluster of Excellence “Controlling Microbes to Fight Infections” (CMFI)

The surfaces of the human body host colonies of microorganisms, known as microbiomes. Along with bacteria which have a positive effect on human health, microbiomes contain potentially life-threatening pathogens. In the past, broad-spectrum antibiotics have often been used to tackle them. Nowadays it is known that this not only promotes resistance to antibiotics – in many cases, it also damages the microbiome as a whole.

CMFI researchers aim to develop new strategies to control microbial mechanisms and fight infections.

Read More

Biomedical Science Research Center “Alexander Fleming” (BSRC FLEMING)

The Biomedical Science Research Center “Alexander Fleming” (BSRC FLEMING) was established through the efforts of Amalia Koutsouri-Fleming, a microbiologist and wife of Alexander Fleming, the Nobel Laureate 1945 in Medicine. She had the vision for a Greek Center of Scientific and Technological Excellence, based on meritocracy, excellence and innovation purposed to attract and develop young Greek researchers.
BSRC FLEMING started its operation in 1999 and is nowadays a top-ranked non-profit research organization of 23 group leaders and 130 researchers, with a mission to perform cutting edge basic and translational research in biomedical sciences, provide state-of the-art training and mentorship to scientists and students of all levels, offer high end scientific and technological services, and engage in technology transfer and innovation. The center is located in an area of 128.000 sq.m. in Vari, a region on the Athenian Riviera. The Fleming Museum of Contemporary Science is also housed on the premises of the research center.

Read More


August Pi i Sunyer Biomedical Research Institute (IDIBAPS)

IDIBAPS is one of the leading biomedical research centers in Spain with an international projection. IDIBAPS is uniquely located in the Campus Clínic in Barcelona, joining efforts with the Faculty of Medicine of the University of Barcelona and the Hospital Clínic of Barcelona to carry out excellent biomedical research and investigate the most common diseases in our society. Our mission is translational research; that is, we look to ensure that the questions that arise at the patient’s bedside find answers in the laboratory and that advances made in the laboratory are translated rapidly to the patient.

Read More

Center for Neuroscience and Cell Biology & Centre for Innovative Biomedicine and Biotechnology

CiBB – Centre for Innovative Biomedicine and Biotechnology, is a Research Center of excellence in the domains of Biomedicine and Biotechnology, which results from a consortium joining CNC-UC — Center for Neuroscience and Cell Biology and iCBR – Coimbra Institute for Clinical and Biomedical Research. In 2024, the Teaming projects MIA-Portugal: Multidisciplinary Institute of Ageing and GeneT – Gene Therapy Center of Excellence have integrated the CiBB multidisciplinary structure.

We can offer an exciting opportunity to delve into the dynamic world of biomedical research and science communication. This fellowship provides hands-on experience in communicating biomedical discoveries through various mediums, including media interactions, video production, and social media management. The FRONTIERS fellows will have the chance to collaborate with an experienced and passionate team, learning and contributing to effective strategies in scientific communication.
The fellowship allows for direct interaction with top researchers in four distinct areas of biomedicine, providing a comprehensive insight into the latest findings and trends in biomedical research.

Read more


Leibniz Institute for Natural Product Research and Infection Biology

We dedicate our research to natural products from micro-organisms and the infection biology of pathogenic fungi. Microbial natural products serving as mediators in the biological communication are essential for our lives. However, they play an ambivalent role in this process: On the one hand, they are involved in the emergence of numerous infectious diseases; on the other hand, they belong to the most important sources of medicinal products like antibiotics.

Read More

Leibniz Institute for Prevention Research and Epidemiology – BIPS

The Leibniz Institute for Prevention Research and Epidemiology – BIPS develops effective strategies for the prevention of chronic, non-communicable diseases. Supporting a healthy life-course early on is our primary goal. The focus of our research is therefore on factors beyond individual diseases, such as lifestyle and environment, biological and social factors, as well as early detection and drug safety. Our research spectrum covers methodological development, the identification of the causes of diseases, and intervention and implementation research. We also offer information to politicians and the general population and provide academic qualification to young scientists. BIPS thus covers the entire cycle of epidemiological research.

Read More

Leibniz Institute for Immunotherapy (LIT)

The Leibniz Institute for Immunotherapy (LIT) develops innovative therapies for the treatment of cancer, autoimmunity, and chronic inflammation. By reprogramming immune cells through synthetic and pharmacologic intervention, we build cells that save lives.

Our scientific activities are structured into three Research Areas: Discovery, Translation, and Clinical Application. All three work in synergy with one another. Our work starts with basic research into the areas of immune regulation, immune metabolism, cancer, and tissue homeostasis. It carries on with a focus on therapy development—spanning the creation of new formats of genetic and pharmacologic cell manipulation and drug-compliant manufacturing processes. Finally, we seek to apply our discoveries in early clinical trials on patients themselves.

Read More


Reinforcing under-utilised crops at the Portuguese living lab GPeaPort – The DIVINFOOD project

In Europe, an increasing number of consumers are embracing plant-based diets and reducing meat consumption. A 2021 survey found that around 30% of Europeans follow a flexitarian diet, focused on plant-base foods with occasional meat consumption. This dietary trend underscores the demand for improved, minimally processed, and nutrient-rich alternatives.
The DIVINFOOD project aims to develop food chains that value under-utilised agrobiodiversity, in order to act against the decline of biodiversity and meet the growing expectations of consumers for healthy, local products that contribute to sustainable food systems. DIVINFOOD operates holistically across the food chain, fostering collaboration among researchers, farmers, processors, market intermediaries, and consumers, to maximize cereals and legumes food chains, realizing their potential for diversified and healthy diets.

Read More